<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02069184</url>
  </required_header>
  <id_info>
    <org_study_id>13-07-144</org_study_id>
    <nct_id>NCT02069184</nct_id>
  </id_info>
  <brief_title>IV Acetaminophen for Acute Post Operative Pain in C-Section Patients</brief_title>
  <official_title>Double Blinded Randomized Placebo Controlled Study in Evaluating the Effectiveness of IV Acetaminophen for Acute Post Operative Pain in C-Section Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Montefiore Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Montefiore Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Post-operative pain management after C-section is an important topic as the number of
      elective c-sections increases each year. Pain is managed either by giving opioids or by using
      non-opioids. The purpose of this study is to evaluate the effectiveness of IV Acetaminophen
      in pain relief and its impact in the usage of post-operative opioid requirements and opioid
      associated complications. The hypothesis is that four doses of IV Acetaminophen in
      conjunction with intrathecal or epidural morphine given to the patients after c-section will
      reduce post-operative opioid requirements and opioid associated complications.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Most of the opioids used are centrally acting drugs like morphine or its derivatives. The
      most common adverse reactions related to systemic administration of opioids are sedation,
      itching, constipation and less commonly, respiratory depression. One of the other management
      strategies for the pain control is the use of non-steroidal anti-inflammatory drugs (NSAIDS).
      Frequent use of NSAIDS is also associated with complications, such as gastric ulcer and
      platelet dysfunction. When compared to other non-NSAIDS, IV acetaminophen is a relatively
      safer drug with quicker onset of action. In an earlier conducted study, the onset of action
      of analgesia for a bolus dose of IV acetaminophen is 3 minutes. IV acetaminophen is FDA
      approved for management of mild to moderate pain. An adverse reaction associated with the
      prolonged usage of IV acetaminophen is hepatic injury. The most common adverse events
      encountered during previous clinical trials were nausea, vomiting, headache and insomnia.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Opioid Requirements in Cesarean Section (C-section) Patient Population</measure>
    <time_frame>24 and 48 hours after Cesarean Section</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual Analog Score (VAS) Pain Score</measure>
    <time_frame>every 6 hours for the first 24 hours after the c-section and there after every 8 hours until the patient is discharged or up to 48 hours</time_frame>
    <description>Post-operative pain was assessed using VAS pain scores (0-10 scale) with 10 being the worst</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants Reporting to be Wide Awake up to 72 Hours After the C-section</measure>
    <time_frame>Percentage of Participants Reporting to be Wide Awake up to 72 hours after the C-section</time_frame>
    <description>Sedation was assessed on a scale of 1-3 (1= wide awake, 2= sleepy but easily aroused, 3= sleepy and difficult to arouse). These assessments were made at the same time points as the pain assessments by the same research assistant. Score 1 is the only good outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>&quot;Percentage of Patients With Adverse Events After the Surgery</measure>
    <time_frame>every 6 hours for the first 24 hours after the c-section and there after every 8 hours until the patient is discharged or upto 72 hours. Finally, 1 week after discharge.</time_frame>
    <description>Subjects were specifically asked about adverse events such as nausea, vomiting, pruritus and breathing difficulties and information regarding their bowel movements. This information was collected on a scale of none, mild, moderate or severe. These are categorical outcomes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Using Patient-controlled Analgesia (PCA) Attempts</measure>
    <time_frame>every 6 hours for the first 24 hours after the c-section and there after every 8 hours until the patient is discharged or upto 72 hours.</time_frame>
    <description>Data were not collected.The use of patient-controlled analgesia (PCA) pumps could have been utilized to standardize rescue medications. This would have allowed the collection of the proportion of subjects that required additional rescue medications. This was another possible endpoint that could have been evaluated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants That Were Re-Hospitalized 1 Week After Discharge</measure>
    <time_frame>From time of discharge to 1 week after discharge</time_frame>
    <description>No patients were re hospitalized in the first 7 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Medication Usage ( NSAIDS)</measure>
    <time_frame>For the first 24 hours after the c-section until the patient is discharged or up to 48 hours</time_frame>
    <description>Compare the percentage of patients using non-opioid pain medication at 24 hours, and 48 hours and had experienced any adverse events.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">66</enrollment>
  <condition>Post-operative Pain</condition>
  <arm_group>
    <arm_group_label>IV Acetaminophen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>IV form, total of 4 doses (each 1000 mg), each every 6th hourly to a maximum dose of 4000 mg in 24 hours.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline as placebo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>IV form, total 4 units, each given every 6th hourly in 24 hours.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>IV Acetaminophen</intervention_name>
    <description>1gm IV. 1st dose at the cord clamping and 3 more doses given every 6th hourly</description>
    <arm_group_label>IV Acetaminophen</arm_group_label>
    <other_name>IV Tylenol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Saline as placebo</intervention_name>
    <description>100ml saline IV. 1st dose of 100 ml at cord clamping and 3 more 100ml doses every 6th hourly.</description>
    <arm_group_label>Saline as placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Elective full term CS patients

          -  Age 18 and above

          -  ASA I-III

        Exclusion Criteria:

          -  Allergic reaction to IV acetaminophen

          -  Not able to understand and sign the research consent

          -  Pregnancy induced hypertension or pre-eclampsia patients

          -  Planned intensive care admission patients

          -  Patients with severe hepatic impairment or active liver diseases (Two fold increase in
             any of the liver enzymes)

          -  Patients with serum creatinine&gt;2mg/dl

          -  For nursing mothers, any evidence of hepatic dysfunction of the new born
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeffrey Bernstein, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Montefiore Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Montefiore Medical Center- Weiler</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>December 2, 2013</study_first_submitted>
  <study_first_submitted_qc>February 19, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 24, 2014</study_first_posted>
  <results_first_submitted>January 22, 2017</results_first_submitted>
  <results_first_submitted_qc>August 8, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">August 22, 2019</results_first_posted>
  <last_update_submitted>August 8, 2019</last_update_submitted>
  <last_update_submitted_qc>August 8, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 22, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Montefiore Medical Center</investigator_affiliation>
    <investigator_full_name>Singh Nair</investigator_full_name>
    <investigator_title>Asst Prof, Anesthesiology</investigator_title>
  </responsible_party>
  <keyword>opioid usage requirements</keyword>
  <keyword>pain</keyword>
  <keyword>IV acetaminophen</keyword>
  <keyword>opioid usage</keyword>
  <keyword>c-section</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>IV Acetaminophen</title>
          <description>IV form, total of 4 doses (each 1000 mg), each every 6th hourly to a maximum dose of 4000 mg in 24 hours.
IV Acetaminophen: 1gm IV. 1st dose at the cord clamping and 3 more doses given every 6th hourly</description>
        </group>
        <group group_id="P2">
          <title>Saline as Placebo</title>
          <description>IV form, total 4 units, each given every 6th hourly in 24 hours.
Saline as placebo: 100ml saline IV. 1st dose of 100 ml at cord clamping and 3 more 100ml doses every 6th hourly.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="33"/>
                <participants group_id="P2" count="33"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="27"/>
                <participants group_id="P2" count="31"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>IV Acetaminophen</title>
          <description>IV form, total of 4 doses (each 1000 mg), each every 6th hourly to a maximum dose of 4000 mg in 24 hours.
IV Acetaminophen: 1gm IV. 1st dose at the cord clamping and 3 more doses given every 6th hourly</description>
        </group>
        <group group_id="B2">
          <title>Saline as Placebo</title>
          <description>IV form, total 4 units, each given every 6th hourly in 24 hours.
Saline as placebo: 100ml saline IV. 1st dose of 100 ml at cord clamping and 3 more 100ml doses every 6th hourly.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="33"/>
            <count group_id="B2" value="33"/>
            <count group_id="B3" value="66"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31" spread="6"/>
                    <measurement group_id="B2" value="31" spread="5"/>
                    <measurement group_id="B3" value="31" spread="5.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="33"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="66"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Opioid Requirements in Cesarean Section (C-section) Patient Population</title>
        <time_frame>24 and 48 hours after Cesarean Section</time_frame>
        <group_list>
          <group group_id="O1">
            <title>IV Acetaminophen</title>
            <description>IV form, total of 4 doses (each 1000 mg), each every 6th hourly to a maximum dose of 4000 mg in 24 hours.
IV Acetaminophen: 1gm IV. 1st dose at the cord clamping and 3 more doses given every 6th hourly</description>
          </group>
          <group group_id="O2">
            <title>Saline as Placebo</title>
            <description>IV form, total 4 units, each given every 6th hourly in 24 hours.
Saline as placebo: 100ml saline IV. 1st dose of 100 ml at cord clamping and 3 more 100ml doses every 6th hourly.</description>
          </group>
        </group_list>
        <measure>
          <title>Opioid Requirements in Cesarean Section (C-section) Patient Population</title>
          <units>mg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>24 hours cumulative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44" spread="23"/>
                    <measurement group_id="O2" value="48" spread="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>48 hours cumulative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="58" spread="20"/>
                    <measurement group_id="O2" value="57" spread="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Visual Analog Score (VAS) Pain Score</title>
        <description>Post-operative pain was assessed using VAS pain scores (0-10 scale) with 10 being the worst</description>
        <time_frame>every 6 hours for the first 24 hours after the c-section and there after every 8 hours until the patient is discharged or up to 48 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>IV Acetaminophen</title>
            <description>IV form, total of 4 doses (each 1000 mg), each every 6th hourly to a maximum dose of 4000 mg in 24 hours.
IV Acetaminophen: 1gm IV. 1st dose at the cord clamping and 3 more doses given every 6th hourly</description>
          </group>
          <group group_id="O2">
            <title>Saline as Placebo</title>
            <description>IV form, total 4 units, each given every 6th hourly in 24 hours.
Saline as placebo: 100ml saline IV. 1st dose of 100 ml at cord clamping and 3 more 100ml doses every 6th hourly.</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Analog Score (VAS) Pain Score</title>
          <description>Post-operative pain was assessed using VAS pain scores (0-10 scale) with 10 being the worst</description>
          <units>scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>0 hr pain after CS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.2" spread="2.9"/>
                    <measurement group_id="O2" value="1.4" spread="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 hours after CS pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.4" spread="2.6"/>
                    <measurement group_id="O2" value="3.6" spread="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 hours after CS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.2" spread="1.9"/>
                    <measurement group_id="O2" value="2.3" spread="2.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>18 hours after CS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.1" spread="2.7"/>
                    <measurement group_id="O2" value="2.9" spread="3.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hours after CS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.0" spread="3.2"/>
                    <measurement group_id="O2" value="5.1" spread="2.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>32 hours after CS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.1" spread="2.4"/>
                    <measurement group_id="O2" value="2.9" spread="2.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>40 hours after CS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.0" spread="2.2"/>
                    <measurement group_id="O2" value="1.2" spread="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>48 hours after CS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.2" spread="2.5"/>
                    <measurement group_id="O2" value="2.6" spread="2.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants Reporting to be Wide Awake up to 72 Hours After the C-section</title>
        <description>Sedation was assessed on a scale of 1-3 (1= wide awake, 2= sleepy but easily aroused, 3= sleepy and difficult to arouse). These assessments were made at the same time points as the pain assessments by the same research assistant. Score 1 is the only good outcome.</description>
        <time_frame>Percentage of Participants Reporting to be Wide Awake up to 72 hours after the C-section</time_frame>
        <group_list>
          <group group_id="O1">
            <title>IV Acetaminophen</title>
            <description>IV form, total of 4 doses (each 1000 mg), each every 6th hourly to a maximum dose of 4000 mg in 24 hours.
IV Acetaminophen: 1gm IV. 1st dose at the cord clamping and 3 more doses given every 6th hourly</description>
          </group>
          <group group_id="O2">
            <title>Saline as Placebo</title>
            <description>IV form, total 4 units, each given every 6th hourly in 24 hours.
Saline as placebo: 100ml saline IV. 1st dose of 100 ml at cord clamping and 3 more 100ml doses every 6th hourly.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants Reporting to be Wide Awake up to 72 Hours After the C-section</title>
          <description>Sedation was assessed on a scale of 1-3 (1= wide awake, 2= sleepy but easily aroused, 3= sleepy and difficult to arouse). These assessments were made at the same time points as the pain assessments by the same research assistant. Score 1 is the only good outcome.</description>
          <units>percentage of patients</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95"/>
                    <measurement group_id="O2" value="95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>&quot;Percentage of Patients With Adverse Events After the Surgery</title>
        <description>Subjects were specifically asked about adverse events such as nausea, vomiting, pruritus and breathing difficulties and information regarding their bowel movements. This information was collected on a scale of none, mild, moderate or severe. These are categorical outcomes.</description>
        <time_frame>every 6 hours for the first 24 hours after the c-section and there after every 8 hours until the patient is discharged or upto 72 hours. Finally, 1 week after discharge.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>IV Acetaminophen</title>
            <description>IV form, total of 4 doses (each 1000 mg), each every 6th hourly to a maximum dose of 4000 mg in 24 hours.
IV Acetaminophen: 1gm IV. 1st dose at the cord clamping and 3 more doses given every 6th hourly</description>
          </group>
          <group group_id="O2">
            <title>Saline as Placebo</title>
            <description>IV form, total 4 units, each given every 6th hourly in 24 hours.
Saline as placebo: 100ml saline IV. 1st dose of 100 ml at cord clamping and 3 more 100ml doses every 6th hourly.</description>
          </group>
        </group_list>
        <measure>
          <title>&quot;Percentage of Patients With Adverse Events After the Surgery</title>
          <description>Subjects were specifically asked about adverse events such as nausea, vomiting, pruritus and breathing difficulties and information regarding their bowel movements. This information was collected on a scale of none, mild, moderate or severe. These are categorical outcomes.</description>
          <units>percentage of patients</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>24 hour nausea</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22"/>
                    <measurement group_id="O2" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hour vomiting</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                    <measurement group_id="O2" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hour itching</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57"/>
                    <measurement group_id="O2" value="63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hour breathing difficulty</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Using Patient-controlled Analgesia (PCA) Attempts</title>
        <description>Data were not collected.The use of patient-controlled analgesia (PCA) pumps could have been utilized to standardize rescue medications. This would have allowed the collection of the proportion of subjects that required additional rescue medications. This was another possible endpoint that could have been evaluated.</description>
        <time_frame>every 6 hours for the first 24 hours after the c-section and there after every 8 hours until the patient is discharged or upto 72 hours.</time_frame>
        <population>None of the participants used PCA pumps so no data could be collected for this outcome measure. PCA was not part of the standard of care at our hospital.</population>
        <group_list>
          <group group_id="O1">
            <title>IV Acetaminophen</title>
            <description>IV form, total of 4 doses (each 1000 mg), each every 6th hourly to a maximum dose of 4000 mg in 24 hours.
IV Acetaminophen: 1gm IV. 1st dose at the cord clamping and 3 more doses given every 6th hourly</description>
          </group>
          <group group_id="O2">
            <title>Saline as Placebo</title>
            <description>IV form, total 4 units, each given every 6th hourly in 24 hours.
Saline as placebo: 100ml saline IV. 1st dose of 100 ml at cord clamping and 3 more 100ml doses every 6th hourly.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Using Patient-controlled Analgesia (PCA) Attempts</title>
          <description>Data were not collected.The use of patient-controlled analgesia (PCA) pumps could have been utilized to standardize rescue medications. This would have allowed the collection of the proportion of subjects that required additional rescue medications. This was another possible endpoint that could have been evaluated.</description>
          <population>None of the participants used PCA pumps so no data could be collected for this outcome measure. PCA was not part of the standard of care at our hospital.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants That Were Re-Hospitalized 1 Week After Discharge</title>
        <description>No patients were re hospitalized in the first 7 days</description>
        <time_frame>From time of discharge to 1 week after discharge</time_frame>
        <group_list>
          <group group_id="O1">
            <title>IV Acetaminophen</title>
            <description>IV form, total of 4 doses (each 1000 mg), each every 6th hourly to a maximum dose of 4000 mg in 24 hours.
IV Acetaminophen: 1gm IV. 1st dose at the cord clamping and 3 more doses given every 6th hourly</description>
          </group>
          <group group_id="O2">
            <title>Saline as Placebo</title>
            <description>IV form, total 4 units, each given every 6th hourly in 24 hours.
Saline as placebo: 100ml saline IV. 1st dose of 100 ml at cord clamping and 3 more 100ml doses every 6th hourly.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants That Were Re-Hospitalized 1 Week After Discharge</title>
          <description>No patients were re hospitalized in the first 7 days</description>
          <units>percentage of patients</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain Medication Usage ( NSAIDS)</title>
        <description>Compare the percentage of patients using non-opioid pain medication at 24 hours, and 48 hours and had experienced any adverse events.</description>
        <time_frame>For the first 24 hours after the c-section until the patient is discharged or up to 48 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>IV Acetaminophen</title>
            <description>IV form, total of 4 doses (each 1000 mg), each every 6th hourly to a maximum dose of 4000 mg in 24 hours.
IV Acetaminophen: 1gm IV. 1st dose at the cord clamping and 3 more doses given every 6th hourly</description>
          </group>
          <group group_id="O2">
            <title>Saline as Placebo</title>
            <description>IV form, total 4 units, each given every 6th hourly in 24 hours.
Saline as placebo: 100ml saline IV. 1st dose of 100 ml at cord clamping and 3 more 100ml doses every 6th hourly.</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Medication Usage ( NSAIDS)</title>
          <description>Compare the percentage of patients using non-opioid pain medication at 24 hours, and 48 hours and had experienced any adverse events.</description>
          <units>percentage of patients</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27"/>
                    <measurement group_id="O2" value="30.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>24 hours, 48 hours and up to one week after surgery</time_frame>
      <desc>Serious and Other (Not Including Serious) Adverse Events</desc>
      <group_list>
        <group group_id="E1">
          <title>IV Acetaminophen</title>
          <description>IV form, total of 4 doses (each 1000 mg), each every 6th hourly to a maximum dose of 4000 mg in 24 hours.
IV Acetaminophen: 1gm IV. 1st dose at the cord clamping and 3 more doses given every 6th hourly</description>
        </group>
        <group group_id="E2">
          <title>Saline as Placebo</title>
          <description>IV form, total 4 units, each given every 6th hourly in 24 hours.
Saline as placebo: 100ml saline IV. 1st dose of 100 ml at cord clamping and 3 more 100ml doses every 6th hourly.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="30" subjects_at_risk="33"/>
                <counts group_id="E2" subjects_affected="24" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="33"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="33"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="33"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Pruritis</sub_title>
                <counts group_id="E1" events="16" subjects_affected="16" subjects_at_risk="33"/>
                <counts group_id="E2" events="15" subjects_affected="15" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Breathing Difficulty</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="33"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>There may be unknown factors that could have biased the results of the study, pain tolerance is not measured in this study, surgeon variation in performing the surgery and lack of standardized post -operative pain management protocol.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Jeffrey Bernstein</name_or_title>
      <organization>Montefiore Medical Center</organization>
      <phone>718-920-4317</phone>
      <email>JBernste@montefiore.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

